Esipov A.V., Martov A.G., Kochetov A.G., Musailov V.A., Ragimov I.G.
Combined prevention of infectious complications of minimally invasive procedures in urology
|
№4 / 2024
|
Perepanova T.S., Kazachenko A.V., Mesropyan S.A., Antonova V.E., Nazirov M.R., Malova Yu.A., Lyubchenko L.N.
Stent-associated urosepsis, personalized bacteriophage therapy
|
№4 / 2024
|
Yakovlev S.V., Gadzhieva Z.K., Suvorova M.P.
Antimicrobial activity of nitrofurans (nitrofurantoin, furazidine and furazidine potassium) against uropatogenic Escherichia Coli isolated from patients with lower urinary tract infections
|
№3 / 2024
|
Lokshin K.L.
Diagnosis and treatment of non-gonococcal urethritis caused by atypical (intracellular) pathogens. What should a urologist know? Review of current clinical guidelines
|
№3 / 2024
|
Pulbere S.A., Kotov S.V., Magomedov M.A., Zheltikova E.A.
Development of purulent-destructive forms of acute pyelonephritis in patients with a history of new coronavirus infection Covid-19
|
№6 / 2023
|
A.V. Zaitsev, I.S. Palagin
Fosfomycin: potential and perspectives
for use in urological practice
|
№6 / 2021
|
S.V. Yakovlev, M.P. Suvorova
Rationale for the choice of an antibiotic for urinary tract infections with an emphasis on the environmental safety of therapy
|
№4 / 2021
|
S.V. Kotov, S.A. Pulbere, N.V. Alesina, V.S. Boyarkin, R.I. Guspanov, S.V. Belomytsev, D.P. Kotova
The problem of antibiotic resistance in patients with urinary tract infection
|
№1 / 2021
|
V.V. Rafalskiy, N.O. Kriukova, D.S. Korenev
Resistance of pathogens of community-acquired urinary tract infections: lessons from russian multicenter microbiological studies
|
№4 / 2020
|
S.K. Zyryanov, O.I. Butranova, A. Al-Ragawi
Modern pharmacotherapy of uncomplicated infections of the lower urinary tract: the position of antibacterial and herbal preparations
|
№2 / 2020
|
I.S. Palagin, M.V. Sukhorukova, A.V. Dekhnich, M.V. Edelstein, T.S. Perepanova, R.S. Kozlov
Current state of antibiotic resistance of pathogens causing community-acquired urinary tract infections in Russia, Belarus and Kazakhstan: results of the international multicenter study “Darmis-2018”
|
№1 / 2020
|
I.A. Aboyan, Yu.N. Orlov, O.A. Voloshina, N.V. Orlov, D.S. Pavlov
Experience of using the antibacterial drug Fosfomycin Esparma for the treatment of acute uncomplicated cystitis in women
|
№4 / 2019
|